BioHemp (BKIT) Discusses International Focus for CBD Distribution in Online Interview

Cannabis

(NEW YORK)–BioHemp International  (OTC: BKIT) announced in an online interview plans for International growth for CBD market, and current status with trading.

Mr. Daniel Blum, the CEO of Biohemp International, Inc., conducted an online interview to discuss current trading status with their public security, and plans to focus Internationally in building CBD distribution channels, and partnerships.

In the interview, when asked about plan in build its distribution network for CBD market, Mr. Blum, the CEO of Biohemp International stated, “…we have revised our plan to expand our focus internationally as the regulatory status on CBD infused products remains unclear with the FDA. We are very confident in the outlook for infused CBD sales in the US in coming years, but feel it’s prudent to expand our outlook internationally, which will allow us to continue to grow our channels, which will give the Company even more leverage in the US once the status of these products are clarified.”

To access transcript of full interview visit https://wallstreetnewscast.com/investors/bkit/

As of July 2019, BioHemp (BKIT) currently has roughly 29 million shares issued and outstanding, with a public float of only 4 million shares, and is traded under ticket symbol “BKIT”

BKIT joins a growing group of CBD infused players, such as Puration, Inc. (OTC: PURA), Kali-Extracts, Inc. (OTC:KALY), as well as others listed below.

CVSI CV Sciences
KGKG Kona Gold Solutions
NBEV New Age Beverages
HIPH American Premium Water
CIIX Chineseinvestors.com
MCOA Marijuana Company of America
RMHB Rocky Mountain High Brands

About BioHemp International, Inc.

Located in New York City, BioHemp International (OTC: BKIT) is an early stage venture firm focused on establishing a portfolio of product brands, and distribution channels, for the growing cannabidiol (CBD) market. The Company’s management team holds years of experience in private equity, startup development, and financial consulting, which they plan to utilize in developing out future growth through strategic rollups and acquisitions. www.biohempinternational.com

Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. In Compliance with SEC Rule 17B WSNC was compensated two thousand three hundred dollars for on going media services. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. As of date of this alert, WSNC, or any of its affiliates, held no positions in securities mentioned above. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
High Risk
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities

Share